| Document And Entity Information - USD ($) | 12 Months Ended | ||
| Jun. 30, 2023 | Sep. 29, 2023 | Dec. 31, 2022 | |
| Document Information Line Items | |||
| Entity Registrant Name | INMED PHARMACEUTICALS INC. | ||
| Trading Symbol | INM | ||
| Document Type | 10-K/A | ||
| Current Fiscal Year End Date | --06-30 | ||
| Entity Common Stock, Shares Outstanding | 3,328,191 | ||
| Entity Public Float | $ 3,180,248 | ||
| Amendment Flag | true | ||
| Amendment Description | We are filing this Amendment No. 1 to our Annual Report on Form 10-K solely for the purpose of updating our auditor’s consent in Exhibit 23.1 to include our Registration Statement on Form S-8 (File No. 333-268356).Outside of the change to the exhibit noted above and the updated certifications of the Chief Executive Officer and Chief Financial Officer, this Form 10-K/A does not otherwise amend, supplement, update or revise any portion of the original Form 10-K which remains unchanged since the date of its filing. Furthermore, this Form 10-K/A does not change any previously reported financial results, nor does it reflect events occurring after the date of the original Form 10-K. Information not affected by this Form 10-K/A remains unchanged and reflects the disclosures made at the time the original Form 10-K was filed. | ||
| Entity Central Index Key | 0001728328 | ||
| Entity Current Reporting Status | Yes | ||
| Entity Voluntary Filers | No | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Well-known Seasoned Issuer | No | ||
| Document Period End Date | Jun. 30, 2023 | ||
| Document Fiscal Year Focus | 2023 | ||
| Document Fiscal Period Focus | FY | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | true | ||
| Entity Shell Company | false | ||
| Entity Ex Transition Period | false | ||
| ICFR Auditor Attestation Flag | false | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Entity File Number | 001-39685 | ||
| Entity Incorporation, State or Country Code | A1 | ||
| Entity Tax Identification Number | 98-1428279 | ||
| Entity Address, Address Line One | Suite 310 – 815 W Hastings | ||
| Entity Address, Address Line Two | Vancouver | ||
| Entity Address, City or Town | B.C | ||
| Entity Address, Country | CA | ||
| Entity Address, Postal Zip Code | V6C 1B4 | ||
| City Area Code | (604) | ||
| Local Phone Number | 669-7207 | ||
| Title of 12(b) Security | Common Stock, no par value | ||
| Security Exchange Name | NASDAQ | ||
| Entity Interactive Data Current | Yes | ||
| Document Financial Statement Error Correction [Flag] | false | ||
| Documents Incorporated by Reference [Text Block] | DOCUMENTS INCORPORATED BY REFERENCE None. | ||
| Auditor Name | Marcum LLP | ||
| Auditor Location | New York, NY | ||
| Auditor Firm ID | 688 |
